Strong Q1; full-year outlook maintained
12/05/22 -"Alcon has started 2022 on a good note, with continued strong growth momentum being witnessed across the segments. While spiralling inflation and FX headwinds, due to rising geopolitical crisis and ..."
Pages
50
Language
English
Published on
12/05/22
You may also be interested by these reports :
19/01/26
Drägerwerk has delivered solid FY25 preliminary numbers. The key surprise was EBIT, which beat consensus by c.18%, reflecting better gross margins ...
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
07/01/26
Yesterday, Meta announced a delay in the international rollout of the Ray-Ban display smart glasses. The market reacted positively to this news, on ...
30/12/25
Despite revising our estimates and target price downward, DiaSorin remains a compelling investment opportunity. This is underpinned by strong ...